BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26613556)

  • 1. Targeting Notch Signaling and Autophagy Increases Cytotoxicity in Glioblastoma Neurospheres.
    Natsumeda M; Maitani K; Liu Y; Miyahara H; Kaur H; Chu Q; Zhang H; Kahlert UD; Eberhart CG
    Brain Pathol; 2016 Nov; 26(6):713-723. PubMed ID: 26613556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged inhibition of glioblastoma xenograft initiation and clonogenic growth following in vivo Notch blockade.
    Chu Q; Orr BA; Semenkow S; Bar EE; Eberhart CG
    Clin Cancer Res; 2013 Jun; 19(12):3224-33. PubMed ID: 23630166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres.
    Ding D; Lim KS; Eberhart CG
    Acta Neuropathol Commun; 2014 Mar; 2():31. PubMed ID: 24685274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch pathway activity identifies cells with cancer stem cell-like properties and correlates with worse survival in lung adenocarcinoma.
    Hassan KA; Wang L; Korkaya H; Chen G; Maillard I; Beer DG; Kalemkerian GP; Wicha MS
    Clin Cancer Res; 2013 Apr; 19(8):1972-80. PubMed ID: 23444212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong therapeutic potential of γ-secretase inhibitor MRK003 for CD44-high and CD133-low glioblastoma initiating cells.
    Tanaka S; Nakada M; Yamada D; Nakano I; Todo T; Ino Y; Hoshii T; Tadokoro Y; Ohta K; Ali MA; Hayashi Y; Hamada J; Hirao A
    J Neurooncol; 2015 Jan; 121(2):239-50. PubMed ID: 25293440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells.
    Kahlert UD; Cheng M; Koch K; Marchionni L; Fan X; Raabe EH; Maciaczyk J; Glunde K; Eberhart CG
    Int J Cancer; 2016 Mar; 138(5):1246-55. PubMed ID: 26422827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J; Kawaguchi KS; Vo H; Haruki N; Gonzalez A; Carbone DP; Dang TP
    Cancer Res; 2007 Sep; 67(17):8051-7. PubMed ID: 17804716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
    Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
    Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6-Shogaol Inhibits Breast Cancer Cells and Stem Cell-Like Spheroids by Modulation of Notch Signaling Pathway and Induction of Autophagic Cell Death.
    Ray A; Vasudevan S; Sengupta S
    PLoS One; 2015; 10(9):e0137614. PubMed ID: 26355461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Notch target Hes1 directly modulates Gli1 expression and Hedgehog signaling: a potential mechanism of therapeutic resistance.
    Schreck KC; Taylor P; Marchionni L; Gopalakrishnan V; Bar EE; Gaiano N; Eberhart CG
    Clin Cancer Res; 2010 Dec; 16(24):6060-70. PubMed ID: 21169257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine or chloroquine-PI3K/Akt pathway inhibitor combinations strongly promote γ-irradiation-induced cell death in primary stem-like glioma cells.
    Firat E; Weyerbrock A; Gaedicke S; Grosu AL; Niedermann G
    PLoS One; 2012; 7(10):e47357. PubMed ID: 23091617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M; Osipo C
    Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy.
    Golden EB; Cho HY; Jahanian A; Hofman FM; Louie SG; Schönthal AH; Chen TC
    Neurosurg Focus; 2014 Dec; 37(6):E12. PubMed ID: 25434381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch signaling contributes to lung cancer clonogenic capacity in vitro but may be circumvented in tumorigenesis in vivo.
    Osanyingbemi-Obidi J; Dobromilskaya I; Illei PB; Hann CL; Rudin CM
    Mol Cancer Res; 2011 Dec; 9(12):1746-54. PubMed ID: 21994468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch signaling activation in pediatric low-grade astrocytoma.
    Brandt WD; Schreck KC; Bar EE; Taylor I; Marchionni L; Raabe E; Eberhart CG; Rodriguez FJ
    J Neuropathol Exp Neurol; 2015 Feb; 74(2):121-31. PubMed ID: 25575134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
    Kristoffersen K; Nedergaard MK; Villingshøj M; Borup R; Broholm H; Kjær A; Poulsen HS; Stockhausen MT
    Cancer Biol Ther; 2014 Jul; 15(7):862-77. PubMed ID: 24755988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Honokiol inhibits melanoma stem cells by targeting notch signaling.
    Kaushik G; Venugopal A; Ramamoorthy P; Standing D; Subramaniam D; Umar S; Jensen RA; Anant S; Mammen JM
    Mol Carcinog; 2015 Dec; 54(12):1710-21. PubMed ID: 25491779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma.
    Zhong C; Shu M; Ye J; Wang X; Chen X; Liu Z; Zhao W; Zhao B; Zheng Z; Yin Z; Gao M; Zhao H; Wang K; Zhao S
    BMC Cancer; 2019 May; 19(1):441. PubMed ID: 31088402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy using Notch and Akt inhibitors is effective for suppressing invasion but not proliferation in glioma cells.
    Jin R; Nakada M; Teng L; Furuta T; Sabit H; Hayashi Y; Demuth T; Hirao A; Sato H; Zhao G; Hamada J
    Neurosci Lett; 2013 Feb; 534():316-21. PubMed ID: 23262078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate.
    Hovinga KE; Shimizu F; Wang R; Panagiotakos G; Van Der Heijden M; Moayedpardazi H; Correia AS; Soulet D; Major T; Menon J; Tabar V
    Stem Cells; 2010 Jun; 28(6):1019-29. PubMed ID: 20506127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.